4202.T

Daicel Corporation [4202.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

4202.T Stock Summary

Earnings have grown 14.98% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

EPS has been increasing for the past 3 quarters (Quarter statements)

4202.T's dividend payments are well covered by cash flows with cash payout ratio of 23.21%.

Earnings are expected to fall -100% next year

4202.T's dividend payments have fallen since the beginning of the year

4202.T has less than 1 year of cash runway

Top 10 Correlated ETFs

4202.T

Top 10 Correlated Stocks

4202.T

In the News

4202.T Financial details

Company Rating

Buy

Market Cap

370.33B

Income

46.76B

Revenue

540.85B

Book val./share

1120.05

Cash/share

319.45

Dividend

Dividend %

2.99%

Employees

11.21K

Optionable

Shortable

Yes

Earnings

31 Oct 2023

P/E

7.76

Forward P/E

PEG

1.42

P/S

0.67

P/B

1.13

P/C

3.98

P/FCF

Quick Ratio

0.92

Current Ratio

Debt / Equity

0.96

LT Debt / Equity

0.66

EPS (TTM)

160.97

EPS next Y

EPS next Q

EPS this Y

33.35%

EPS next Y

EPS next 5Y

EPS last 5Y

5.67%

Revenue last 5Y

2.97%

Revenue Q/Q

-2.03%

EPS Q/Q

35.59%

SMA20

10.95%

SMA50

1.41%

SMA100

21.1%

Inst Own

Inst Trans

ROA

ROE

16%

ROC

0.07%

Gross Margin

26%

Oper. Margin

Profit Margin

Payout

Shs Outstand

285.64M

Shs Float

252.7M

Target Price

52W Range

822.0-1346.0

52W High

-5.65%

52W Low

+54.5%

RSI

Rel Volume

0.74

Avg Volume

1.09M

Volume

806.1K

Perf Week

-3.97%

Perf Month

8.87%

Perf Quarter

29.2%

Perf Half Y

30.66%

Beta

0.669669

Volatility

10.2%, 64.07%

Prev Close

-1.66%

Price

1270

Change

-1.17%

4202.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
Revenue per share	1.39K	1.28K	1.3K	1.56K	1.84K
Net income per share	105.38	35.6	65.18	104.14	138.87
Operating cash flow per share	174.7	177.96	191.34	143.26	91.64
Free cash flow per share	44.61	33.85	69.7	-14.92	-85.6
Cash per share	359.04	253.22	302.65	301.64	294.21
Book value per share	1.17K	1.13K	786.42	906.37	1.01K
Tangible book value per share	1.23K	1.18K	774.99	897.91	1.02K
Share holders equity per share	1.17K	1.13K	786.42	906.37	1.01K
Interest debt per share	314.87	281.94	888.72	939.18	1.09K
Market cap	411.03B	253.57B	257.69B	245.19B	292.96B
Enterprise value	401.28B	262.26B	434.46B	437.57B	516.95B
P/E ratio	11.64	22.16	13.07	7.85	7.2
Price to sales ratio	0.88	0.61	0.65	0.52	0.54
POCF ratio	7.02	4.43	4.45	5.7	10.91
PFCF ratio	27.5	23.31	12.22	-54.76	-11.68
P/B Ratio	1.04	0.7	1.08	0.9	0.99
PTB ratio	1.04	0.7	1.08	0.9	0.99
EV to sales	0.86	0.64	1.1	0.94	0.96
Enterprise value over EBITDA	4.68	4.16	6.87	5.04	6.08
EV to operating cash flow	6.86	4.59	7.51	10.18	19.26
EV to free cash flow	26.85	24.1	20.61	-97.71	-20.62
Earnings yield	0.09	0.05	0.08	0.13	0.14
Free cash flow yield	0.04	0.04	0.08	-0.02	-0.09
Debt to equity	0.26	0.25	1.13	1.03	1.08
Debt to assets	0.16	0.15	0.42	0.4	0.42
Net debt to EBITDA	-0.11	0.14	2.79	2.22	2.63
Current ratio	2.82	2.81	2.78	2.34	1.84
Interest coverage	43.18	25.27	26.55	37.25	33.18
Income quality	1.09	3.43	1.75	0.93	0.49
Dividend Yield	0.03	0.04	0.04	0.04	0.04
Payout ratio	0.31	0.91	0.53	0.31	0.26
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.02	0.02	0.02	0.01	0.01
Capex to operating cash flow	-0.74	-0.81	-0.64	-1.1	-1.93
Capex to revenue	-0.09	-0.11	-0.09	-0.1	-0.1
Capex to depreciation	-1.4	-1.54	-1.34	-1.68	-1.64
Stock based compensation to revenue	0	0	0	0	0
Graham number	1.67K	950.56	1.07K	1.46K	1.77K
ROIC	0.08	0.05	0.04	0.06	0.06
Return on tangible assets	0.05	0.02	0.03	0.05	0.05
Graham Net	58.01	-17.73	-593.99	-602.58	-697.19
Working capital	228.53B	191.81B	199.96B	206.35B	185.77B
Tangible asset value	410.57B	379.2B	234.39B	269.48B	299.24B
Net current asset value	122.49B	92.63B	-82.86B	-59.05B	-48.55B
Invested capital	0.26	0.25	1.13	1.03	1.08
Average receivables	94.39B	84.84B	86.33B	97.86B	102.05B
Average payables	55.07B	49.47B	47.21B	55.65B	59.03B
Average inventory	117.72B	121.78B	113.04B	125.33B	159.59B
Days sales outstanding	70.8	70.29	86.4	80	68.88
Days payables outstanding	59.46	54.44	63.93	68.59	52.27
Days of inventory on hand	139.08	142.01	140.57	157.38	164.88
Receivables turnover	5.16	5.19	4.22	4.56	5.3
Payables turnover	6.14	6.71	5.71	5.32	6.98
Inventory turnover	2.62	2.57	2.6	2.32	2.21
ROE	0.09	0.03	0.08	0.11	0.14
Capex per share	-130.09	-144.1	-121.64	-158.18	-177.24

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q1

Metric	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30
Revenue per share	432.8	467.53	467.63	465.23	457.94
Net income per share	30.11	45	24.82	38.8	52.46
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	343.63	295.47	302.78	300.34	319.45
Book value per share	982.35	1.03K	963.97	1.03K	1.12K
Tangible book value per share	974.29	1.02K	951.64	1.04K	1.13K
Share holders equity per share	982.35	1.03K	963.97	1.03K	1.12K
Interest debt per share	1.02K	981.42	1.08K	1.11K	1.08K
Market cap	248.1B	251.65B	282.4B	286.98B	367.32B
Enterprise value	448.15B	455.78B	513.22B	510.97B	575.38B
P/E ratio	6.97	4.73	9.62	6.44	6.13
Price to sales ratio	1.94	1.82	2.04	2.15	2.81
POCF ratio	0	0	0	0	0
PFCF ratio	0	0	0	0	0
P/B Ratio	0.85	0.83	0.99	0.97	1.15
PTB ratio	0.85	0.83	0.99	0.97	1.15
EV to sales	3.5	3.3	3.71	3.83	4.4
Enterprise value over EBITDA	28.35	30.18	51.56	40.54	43.89
EV to operating cash flow	0	0	0	0	0
EV to free cash flow	0	0	0	0	0
Earnings yield	0.04	0.05	0.03	0.04	0.04
Free cash flow yield	0	0	0	0	0
Debt to equity	1.03	0.95	1.12	1.08	0.96
Debt to assets	0.41	0.39	0.42	0.42	0.39
Net debt to EBITDA	12.65	13.52	23.19	17.77	15.87
Current ratio	2.27	2.2	1.78	1.84	2
Interest coverage	35.88	33.67	24.51	32.66	21.81
Income quality	0	0	0	0	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.01	0.01	0.01	0.01	0.01
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	815.76	1.02K	733.64	947.61	1.15K
ROIC	0.01	0.01	0.01	0.02	0.01
Return on tangible assets	0.01	0.02	0.01	0.01	0.02
Graham Net	-612.24	-607.07	-701.86	-711.71	-683.04
Working capital	221.73B	217.07B	179.1B	185.77B	203.98B
Tangible asset value	288.11B	300.7B	281.41B	299.24B	324.1B
Net current asset value	-45.94B	-37.21B	-57.26B	-48.55B	-40.27B
Invested capital	1.03	0.95	1.12	1.08	0.96
Average receivables	103.81B	105.55B	105.94B	103.68B	99.36B
Average payables	63.45B	65.55B	66.18B	61.23B	54.98B
Average inventory	151.45B	168.91B	177.5B	177.63B	178.46B
Days sales outstanding	73.88	69.03	68.88	68.44	66.86
Days payables outstanding	65.2	59.23	57.73	51.2	49.86
Days of inventory on hand	161.34	158.61	155.09	161.51	166.64
Receivables turnover	1.22	1.3	1.31	1.31	1.35
Payables turnover	1.38	1.52	1.56	1.76	1.8
Inventory turnover	0.56	0.57	0.58	0.56	0.54
ROE	0.03	0.04	0.03	0.04	0.05
Capex per share	0	0	0	0	0

4202.T Dividend History

4202.T Frequently Asked Questions

What is Daicel Corporation stock symbol ?

Daicel Corporation is a JP stock and trading under the symbol 4202.T

What is Daicel Corporation stock quote today ?

Daicel Corporation stock price is $1270 today.

Is Daicel Corporation stock public?

Yes, Daicel Corporation is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.09M
Market Capitalization 370.33B
Employee 11.21K
CEO Mr. Yoshimi Ogawa
Headquarters Osaka,JP
IPO Date 2001-01-01
Website https://www.daicel.com

Daicel Corporation manufactures and sells cellulosic derivatives, organic chemicals, plastics, pyrotechnic devices, and other products in Japan, Asia, North America, and Europe. It operates through Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and Others segments. The company offers 1,3-Butylene glycol, polyglycerin, and thickener for cosmetics; natural health food materials and supplements; and chiral and achiral columns, chiral reagents, bio reagents, and DNA and RNA-based probes, as well as analytical/purification/synthesis/formulation services, and analytical tools services for pharmaceuticals. It also provides triacetylcellulose and films for display market; solvent for electronic materials, polymers for resist, and semiconductor process cleaning agents; and optical parts and lens units, silver nanoparticle inks, and organic semiconductor devices for visualization technology. In addition, the company offers inflators for air bags and pyro-fuse for automotive market, as well as safety device for non-mobility products; acetic acid and derivatives, cellulose acetate, acetate tow, and other raw materials for resins and inks, and solvents for paints; and cycloaliphatic epoxies, caprolactone, ketene derivatives, alkylamines, and other raw materials for electrical materials and coatings. Further, it provides a range of plastics, such as engineering plastics, plastic compound products, functional sheets, formed trays, and packaging films for engineering plastics segment. Additionally, the company manufactures and distributes water treatment systems and diffusers for a range of industrial applications. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.